<DOC>
	<DOCNO>NCT01697969</DOCNO>
	<brief_summary>The purpose study descriptively evaluate corneal structure allergic conjunctivitis patient .</brief_summary>
	<brief_title>Confocal Analysis Corneal Structures Symptomatic Allergic Conjunctivitis Patients</brief_title>
	<detailed_description>Heidelberg Retina Tomograph ( HRT ) use descriptively evaluate corneal structure assess immune cell status allergic conjunctivitis patient pre- post-treatment olopatadine 0.2 % relation normative database .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Read , sign , date Ethics Committee review approve informed consent form . Females childbearing potential : Are breastfeed ; Do intend become pregnant duration study ; Are use adequate birth control method agree continue duration study . Able read , understand answer question investigator . Willing able attend require study visit follow direction stipulate protocol investigator . History allergic conjunctivitis ( within past 12 month ) active sign symptom ocular allergy treatment necessary , opinion investigator . Visual acuity correctable 20/30 ( Snellen ) good eye distance without glass correction . Ocular health within normal limit determine investigator . No contact lens wear 14 day prior enrollment willing wear contact lenses duration study . Willing follow 14day washout period due contraindicate medication use , deem necessary investigator . Other protocoldefined inclusion criterion may apply . Contraindications hypersensitivity use test article component . Inability unwillingness follow study instruction complete study visit require . Only one sight eye visual acuity correctable 20/30 ( Snellen ) eye Screening Visit . Ocular trauma within 6 month prior Visit 1 either eye . Any ocular surgical intervention within six month prior Visit 1 anticipation ocular surgery study . Presumed actual ocular infection within 30 day prior Visit 1 . Any severe serious ocular condition significant illness . Any abnormal slitlamp finding time Screening Visit . Contact lens wear within 14 day prior study start unwillingness undergo washout period 14 day ; unwilling wear contact lenses duration study . Use overthecounter ( OTC ) ocular medication within past 14 day unless willing follow wash period . Use topical systemic ocular medication require long twoweek washout period . Participation investigational study 30day period entry study ( i.e. , Visit 1 ) concomitantly study . Women pregnant , nursing , childbearing potential utilizing adequate birth control measure . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>allergic conjunctivitis</keyword>
	<keyword>Pataday</keyword>
	<keyword>Olopatadine</keyword>
</DOC>